@article{AMR-X:2024:10.1016/S2666-5247(24)00003-X,
author = {AMR-X, Collaborators},
doi = {10.1016/S2666-5247(24)00003-X},
journal = {The Lancet Microbe},
pages = {e500--e507},
title = {System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework},
url = {http://dx.doi.org/10.1016/S2666-5247(24)00003-X},
volume = {5},
year = {2024}
}

Download

TY  - JOUR
AB  - Antimicrobial resistance (AMR) threatens human, animal, and environmental health. Acknowledging the urgency of addressing AMR, an opportunity exists to extend AMR action-focused research beyond the confines of an isolated biomedical paradigm. An AMR learning system, AMR-X, envisions a national network of health systems creating and applying optimal use of antimicrobials on the basis of their data collected from the delivery of routine clinical care. AMR-X integrates traditional AMR discovery, experimental research, and applied research with continuous analysis of pathogens, antimicrobial uses, and clinical outcomes that are routinely disseminated to practitioners, policy makers, patients, and the public to drive changes in practice and outcomes. AMR-X uses connected data-to-action systems to underpin an evaluation framework embedded in routine care, continuously driving implementation of improvements in patient and population health, targeting investment, and incentivising innovation. All stakeholders co-create AMR-X, protecting the public from AMR by adapting to continuously evolving AMR threats and generating the information needed for precision patient and population care.
AU  - AMR-X,Collaborators
DO  - 10.1016/S2666-5247(24)00003-X
EP  - 507
PY  - 2024///
SN  - 2666-5247
SP  - 500
TI  - System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework
T2  - The Lancet Microbe
UR  - http://dx.doi.org/10.1016/S2666-5247(24)00003-X
UR  - https://www.ncbi.nlm.nih.gov/pubmed/38461831
UR  - http://hdl.handle.net/10044/1/111593
VL  - 5
ER  - 

Download